Global leaders from life science and healthcare industry are interested in investing into other countries. Ukraine healthcare system is undergoing the most significant transformation in decades and has an up-and-coming potential for placing of products, solutions and assets here. Many life sciences, healthcare and health tech companies have already entered the market, launched R&D activities, placed products, or even invested in local facilities. Some others may have doubts or know too little about the market and its opportunities.
In a view of this, Joint Chamber of Commerce (JCC) Switzerland-Eastern Europe (non-EU), Central Asia, South Caucasus, Novartis, Henniger Winkelmann Consulting and CMS Ukraine (CMS Cameron McKenna Nabarro Olswang) aimed to hold a joint online event “Ukraine’s Life Sciences and Healthcare Sector: Recent Developments and Opportunities” on 12 October 2021 devoted to background, outlook and ongoing developments in Life Sciences and Healthcare sectors in Ukraine with hosting best sector experts.
Oleksandr Komarida, First Deputy Minister of Health of Ukraine
Manana Gamisoniya, General Manager, Novartis Pharma Services AG in Ukraine
Borys Danevych, Partner, Head of Life Sciences and Healthcare, CMS Ukraine (CMS Cameron McKenna Nabarro Olswang)
Sven Henniger, Partner Henniger Winkelmann Consulting (HWC LLC), JCC Board Member and Head, JCC Ukraine Chapter
You will learn about:
– Pharma & biotech sector – background, outlook and ongoing reforms
– Medical devices sector – outlook and ongoing developments
– Healthcare sector – outlook and ongoing developments
– Health Tech sector – at a glance
Working language: English
#healthcare #health #innovation #investing #opportunities #transformation #lifesciences #tech #event #europe #pharma #biotech #medicaldevices #healthtech